ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $25,000 | +31.6% | 36,371 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | -29.6% | 36,371 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | -98.1% | 36,371 | -97.6% | 0.00% | – |
| Q1 2020 | $1,392,000 | -53.6% | 1,492,994 | +1.6% | 0.00% | – |
| Q4 2019 | $2,997,000 | -26.1% | 1,469,088 | +3.9% | 0.00% | – |
| Q3 2019 | $4,057,000 | -86.3% | 1,413,573 | -63.3% | 0.00% | -100.0% |
| Q2 2019 | $29,582,000 | -33.3% | 3,856,844 | +15.7% | 0.00% | -33.3% |
| Q1 2019 | $44,320,000 | +5.6% | 3,334,842 | +23.7% | 0.00% | -25.0% |
| Q4 2018 | $41,989,000 | -20.2% | 2,695,081 | +0.6% | 0.00% | 0.0% |
| Q3 2018 | $52,622,000 | -1.6% | 2,677,759 | +43.6% | 0.00% | 0.0% |
| Q2 2018 | $53,501,000 | -9.5% | 1,864,294 | -25.4% | 0.00% | -20.0% |
| Q1 2018 | $59,132,000 | +12.4% | 2,500,294 | +1.9% | 0.01% | +25.0% |
| Q4 2017 | $52,606,000 | +1.8% | 2,452,508 | +12.2% | 0.00% | 0.0% |
| Q3 2017 | $51,671,000 | +5.9% | 2,185,006 | -11.8% | 0.00% | 0.0% |
| Q2 2017 | $48,783,000 | +43.0% | 2,476,033 | +52.4% | 0.00% | +33.3% |
| Q1 2017 | $34,120,000 | +9.9% | 1,624,743 | -1.6% | 0.00% | 0.0% |
| Q4 2016 | $31,047,000 | +0.2% | 1,651,234 | +11.2% | 0.00% | 0.0% |
| Q3 2016 | $30,986,000 | -17.8% | 1,484,298 | +0.4% | 0.00% | -25.0% |
| Q2 2016 | $37,707,000 | -2.0% | 1,478,289 | +1.6% | 0.00% | 0.0% |
| Q1 2016 | $38,494,000 | -31.1% | 1,455,471 | +11.5% | 0.00% | -33.3% |
| Q4 2015 | $55,849,000 | +36.4% | 1,305,511 | -15.5% | 0.01% | +20.0% |
| Q3 2015 | $40,942,000 | -24.0% | 1,544,313 | -4.5% | 0.01% | -16.7% |
| Q2 2015 | $53,877,000 | +15.1% | 1,616,364 | +14.9% | 0.01% | +20.0% |
| Q1 2015 | $46,826,000 | -3.4% | 1,406,916 | +18.6% | 0.01% | 0.0% |
| Q4 2014 | $48,482,000 | +11.7% | 1,186,214 | -7.4% | 0.01% | 0.0% |
| Q3 2014 | $43,411,000 | -2.0% | 1,281,361 | -2.5% | 0.01% | 0.0% |
| Q2 2014 | $44,319,000 | -15.9% | 1,314,725 | -5.4% | 0.01% | -16.7% |
| Q1 2014 | $52,678,000 | -33.1% | 1,389,691 | -52.5% | 0.01% | +20.0% |
| Q4 2013 | $78,745,000 | +56.8% | 2,923,824 | +99.6% | 0.01% | -16.7% |
| Q3 2013 | $50,215,000 | +7.6% | 1,464,852 | +3.6% | 0.01% | 0.0% |
| Q2 2013 | $46,657,000 | – | 1,414,286 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|